InvestSMART

Alcidion Group Limited (ASX:ALC)

ALERT: Price-sensitive ASX Announcement for ALC
Current share price for ALC : $0.089 -0.021 (-19.09%)+
Announcement
Release
26 Feb 2026 7:54AM
Price at Release
$0.110
Full Release
download
Summary
The H1 FY26 Results Presentation for Alcidion Group Limited highlights the company's financial and operational performance. Key financial metrics showed growth, with a notable increase in recurring revenue driving a significant uplift in EBITDA and achieving a maiden H1 NPAT. The company has a strong global presence, enhancing healthcare systems in countries such as the UK, Australia, and New Zealand, with plans for geographical expansion into Canada, Saudi Arabia, and UAE. Alcidion's flagship product, Miya Precision, continues to gain traction, offering real-time clinical decision support and improving healthcare delivery efficiency. The company maintains a robust balance sheet with no debt and a cash position of $14.2 million, supporting its growth strategies which include scaling in existing markets, evolving product functionality, and entering new markets.
Key Points
  • Growth in key financial metrics for H1 FY26.
  • Increase in recurring revenue and EBITDA uplift.
  • Global presence in the UK, Australia, and New Zealand.
  • Geographical expansion plans to Canada, Saudi Arabia, and UAE.
  • Flagship product Miya Precision enhances healthcare delivery.
  • Strong balance sheet with no debt, $14.2 million cash.
  • Strategies include market scaling, product functionality enhancement, and new market entry.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.